Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Graefen

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Prostate Cancer and Prostatic Diseases|December 24, 2002
Ratio free/total PSA (%f-PSA) in men with total PSA 0.5-3 ng/ml: improvement for prostate cancer detection?P Hammerer, M Graefen, R P Henke, et al.
The Keio Journal of Medicine|December 1, 1995
High-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH)T Ebert, M Graefen, S Miller, et al.
Der Urologe. Ausg. A|March 21, 2009
[The value of real-time elastography in the diagnosis of prostate cancer]G Salomon, M Graefen, H Heinzer, et al.
The Journal of Urology|May 23, 1998
Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinomaS Conrad, M Graefen, U Pichlmeier, et al.
Anaesthesia|August 23, 2002
A comparison of anaesthetic techniques for shock wave lithotripsy: the use of a remifentanil infusion alone compared to intermittent fentanyl boluses combined with a low dose propofol infusionM A Burmeister, P Brauer, M Wintruff, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2003
Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zoneA Erbersdobler, S Huhle, J Palisaar, et al.
Der Urologe. Ausg. A|April 24, 2001
[Nerve-sparing radical retropubic prostatectomy. Results of a patient survey]J Noldus, U Michl, M Graefen, et al.
European Urology|August 15, 2000
Advanced prostate cancer is associated with a decrease in serum luteinizing hormoneH Hilz, M Graefen, J Noldus, et al.
The Journal of Urology|February 7, 2001
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancerA Haese, C Becker, J Noldus, et al.
BJU International|March 27, 2003
Differences in biopsy features between prostate cancers located in the transition and peripheral zoneH Augustin, A Erbersdobler, M Graefen, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Prostate Cancer and Prostatic Diseases|December 24, 2002
Ratio free/total PSA (%f-PSA) in men with total PSA 0.5-3 ng/ml: improvement for prostate cancer detection?P Hammerer, M Graefen, R P Henke, et al.
The Keio Journal of Medicine|December 1, 1995
High-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH)T Ebert, M Graefen, S Miller, et al.
Der Urologe. Ausg. A|March 21, 2009
[The value of real-time elastography in the diagnosis of prostate cancer]G Salomon, M Graefen, H Heinzer, et al.
The Journal of Urology|May 23, 1998
Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinomaS Conrad, M Graefen, U Pichlmeier, et al.
Anaesthesia|August 23, 2002
A comparison of anaesthetic techniques for shock wave lithotripsy: the use of a remifentanil infusion alone compared to intermittent fentanyl boluses combined with a low dose propofol infusionM A Burmeister, P Brauer, M Wintruff, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2003
Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zoneA Erbersdobler, S Huhle, J Palisaar, et al.
Der Urologe. Ausg. A|April 24, 2001
[Nerve-sparing radical retropubic prostatectomy. Results of a patient survey]J Noldus, U Michl, M Graefen, et al.
European Urology|August 15, 2000
Advanced prostate cancer is associated with a decrease in serum luteinizing hormoneH Hilz, M Graefen, J Noldus, et al.
The Journal of Urology|February 7, 2001
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancerA Haese, C Becker, J Noldus, et al.
BJU International|March 27, 2003
Differences in biopsy features between prostate cancers located in the transition and peripheral zoneH Augustin, A Erbersdobler, M Graefen, et al.
Pageof 12